Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Walster who wrote (1005)	7/14/1998 10:51:00 PM
From: wolfdog2	Read Replies (1) of 1491

Don, I disagree with your conclusion that a 3 to 4 year wait is of little consequence to PARS stock. I think that you have misread what people were saying. The stock should move up as PARS reaches various milestones, such as signing a partner, starting P3, etc. But if the market is rational (and frequently it isn't and just now it clearly isn't) then the longer into the future one has to peer in order to see earnings, the greater the discount one should apply to those future earnings. So, the push out will hurt the stock, but the stock doesn't have to await FDA approval in order to move up. Heck, PARS current market cap doesn't reflect the products that have already been approved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next